Evidence map›Paper›PMID 29318147›Full record

ArticleBioMed research international2017

Resveratrol Inhibits Propagation of

Ivan M Petyaev, Nayilia A Zigangirova, Elena Y Morgunova, Nigel H Kyle, Elena D Fedina, Yuriy K Bashmakov

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Frontiers in neuroscience · 2024
    Review
  3. Better In Vitro Tools for ExploringLife (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2022
    Review
  6. Review
  7. Heliyon · 2021
    Article
  8. Article
  9. Article
  10. Advances in urology · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ivan M PetyaevLycotec Ltd., Granta Park, Cambridge CB21 6GP, UK.ORCID 0000-0001-8201-6863
Nayilia A ZigangirovaDepartment of Medical Microbiology, Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health, 18 Gamaleya Str., Moscow 123098, Russia.
Elena Y MorgunovaDepartment of Medical Microbiology, Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health, 18 Gamaleya Str., Moscow 123098, Russia.
Nigel H KyleLycotec Ltd., Granta Park, Cambridge CB21 6GP, UK.
Elena D FedinaDepartment of Medical Microbiology, Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health, 18 Gamaleya Str., Moscow 123098, Russia.
Yuriy K BashmakovLycotec Ltd., Granta Park, Cambridge CB21 6GP, UK.ORCID 0000-0002-2265-3817
Lycotec (United Kingdom) · GBMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (RESV), an antifungal compound from grapes and other plants, has a distinct ability to inhibit the

Indexed as

AnimalsBacterial ProteinsCell LineChlamydia InfectionsChlamydia trachomatisDose-Response Relationship, DrugGene Expression Regulation, BacterialMiceResveratrolStilbenesBacterial ProteinsResveratrolStilbenes

Identifiers

PMID29318147
PMCPMC5727650
OpenAlexW2769909890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.